Case of mononeuritis multiplex onset with rituximab therapy for Waldenström's macroglobulinemia

Michelle M Mauermann, Matthew L. Ryan, Joon Shik Moon, Christopher Jon Klein

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Waldenström's macroglobulinemia (WM) is a lymphoplasmacytic disorder with associated monoclonal gammopathy. A wide variety of neuropathies can be associated with WM, but most commonly it is a mild length-dependent sensory neuropathy of unclear etiology. Rituximab is a monoclonal antibody which suppresses mature B-cell populations. It has increasingly been used in wide applications including WM, especially in those cases with severe neuropathy. The highlighted case provides an example of rituximab treatment complication in a WM patient with mild sensory neuropathy that evolved to multiple mononeuropathies with features of systemic vasculitis and unusual conversion of type I to type II cryoglobulinemia.

Original languageEnglish (US)
Pages (from-to)240-243
Number of pages4
JournalJournal of the Neurological Sciences
Volume260
Issue number1-2
DOIs
StatePublished - Sep 15 2007

Fingerprint

Mononeuropathies
Waldenstrom Macroglobulinemia
Cryoglobulinemia
Systemic Vasculitis
Paraproteinemias
Therapeutics
B-Lymphocytes
Monoclonal Antibodies
Rituximab
Population

Keywords

  • Cryoglobulinemia
  • Mononeuritis multiplex
  • Neuropathy
  • Rituximab
  • Vasculitis
  • Waldenström's macroglobulinemia

ASJC Scopus subject areas

  • Aging
  • Clinical Neurology
  • Surgery
  • Developmental Neuroscience
  • Neurology
  • Neuroscience(all)

Cite this

Case of mononeuritis multiplex onset with rituximab therapy for Waldenström's macroglobulinemia. / Mauermann, Michelle M; Ryan, Matthew L.; Moon, Joon Shik; Klein, Christopher Jon.

In: Journal of the Neurological Sciences, Vol. 260, No. 1-2, 15.09.2007, p. 240-243.

Research output: Contribution to journalArticle

@article{15d48a1b45764268b98b76b817bcc77a,
title = "Case of mononeuritis multiplex onset with rituximab therapy for Waldenstr{\"o}m's macroglobulinemia",
abstract = "Waldenstr{\"o}m's macroglobulinemia (WM) is a lymphoplasmacytic disorder with associated monoclonal gammopathy. A wide variety of neuropathies can be associated with WM, but most commonly it is a mild length-dependent sensory neuropathy of unclear etiology. Rituximab is a monoclonal antibody which suppresses mature B-cell populations. It has increasingly been used in wide applications including WM, especially in those cases with severe neuropathy. The highlighted case provides an example of rituximab treatment complication in a WM patient with mild sensory neuropathy that evolved to multiple mononeuropathies with features of systemic vasculitis and unusual conversion of type I to type II cryoglobulinemia.",
keywords = "Cryoglobulinemia, Mononeuritis multiplex, Neuropathy, Rituximab, Vasculitis, Waldenstr{\"o}m's macroglobulinemia",
author = "Mauermann, {Michelle M} and Ryan, {Matthew L.} and Moon, {Joon Shik} and Klein, {Christopher Jon}",
year = "2007",
month = "9",
day = "15",
doi = "10.1016/j.jns.2007.04.009",
language = "English (US)",
volume = "260",
pages = "240--243",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Case of mononeuritis multiplex onset with rituximab therapy for Waldenström's macroglobulinemia

AU - Mauermann, Michelle M

AU - Ryan, Matthew L.

AU - Moon, Joon Shik

AU - Klein, Christopher Jon

PY - 2007/9/15

Y1 - 2007/9/15

N2 - Waldenström's macroglobulinemia (WM) is a lymphoplasmacytic disorder with associated monoclonal gammopathy. A wide variety of neuropathies can be associated with WM, but most commonly it is a mild length-dependent sensory neuropathy of unclear etiology. Rituximab is a monoclonal antibody which suppresses mature B-cell populations. It has increasingly been used in wide applications including WM, especially in those cases with severe neuropathy. The highlighted case provides an example of rituximab treatment complication in a WM patient with mild sensory neuropathy that evolved to multiple mononeuropathies with features of systemic vasculitis and unusual conversion of type I to type II cryoglobulinemia.

AB - Waldenström's macroglobulinemia (WM) is a lymphoplasmacytic disorder with associated monoclonal gammopathy. A wide variety of neuropathies can be associated with WM, but most commonly it is a mild length-dependent sensory neuropathy of unclear etiology. Rituximab is a monoclonal antibody which suppresses mature B-cell populations. It has increasingly been used in wide applications including WM, especially in those cases with severe neuropathy. The highlighted case provides an example of rituximab treatment complication in a WM patient with mild sensory neuropathy that evolved to multiple mononeuropathies with features of systemic vasculitis and unusual conversion of type I to type II cryoglobulinemia.

KW - Cryoglobulinemia

KW - Mononeuritis multiplex

KW - Neuropathy

KW - Rituximab

KW - Vasculitis

KW - Waldenström's macroglobulinemia

UR - http://www.scopus.com/inward/record.url?scp=34547657335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547657335&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2007.04.009

DO - 10.1016/j.jns.2007.04.009

M3 - Article

C2 - 17537458

AN - SCOPUS:34547657335

VL - 260

SP - 240

EP - 243

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -